Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Deltex reaps benefit of NICE recommendation

Blood monitoring specialist Deltex Medical saw sales rise in the first half of this year thanks to growing market acceptance of its CardioQ-ODM product for managing surgery patients.

The Aim-listed firm saw overall sales cross the £3 million mark for the six months ended 30 June 2011, up by around £100,000 on the same period last year.

The company also announced that the increased adoption of CardioQ-ODM in the UK had generated over £400,000 in additional revenue, but that this was partly offset by a reduction in sales of monitors in the Middle East.

In March, the National Institute for Health and Clinical Excellence (NICE) published guidance to the NHS in England recommending CardioQ-ODM for use in almost all major and high risk surgery. Commenting on this development, Deltex said the company's UK success was dependent on “the rate of growth in surgical probe sales”. It added that “this has increased since the NICE recommendation”.

However, turning to its international ambitions, the firm pointed out that in the US, clinical awareness of optimising vascular fluids among surgery patients “remains some way behind the UK and continental Europe”.

It also said that as a result of uncertainties caused by political unrest in the Middle East, the company has redeployed some of its resources to other potential markets with developed healthcare systems, including Scandanavia, Canada and Australia. Deltex chairman Nigel Keen claimed the firm is well-positioned to roll-out the CardioQ-ODM “into a number of export markets”. 

Posted on: 18/07/2011

Latest news stories

19/11/2018
Health Education England has appointed Sir David Behan as chair – effective from 1 December.
19/11/2018
NHS England has lifted the safety restrictions which limited the types of patients eligible to use GP at Hand services following a NHS clinical review.
16/11/2018
Care provider Regard Group has appointed Tracy Kite (pictured) as director of learning and leadership development.
15/11/2018
The McAvoy Group has been awarded a £15 million contract for the offsite construction of a new wing at Northumbria Specialist Emergency Care Hospital, Cramlington.
14/11/2018
Independent investment manager Albion Capital has invested £5 million in The Evewell, a fully-integrated medical centre specialising in reproductive and gynaecological health.


Civica


HealthInvestor blog
The Care Quality Commission is finding its voice as a regulator, but is anyone listening?

Click here to view the HealthInvestor blog


An interest in people rather than machines led to Andrew Lennox dedicating his career to improving patient outcomes
The Care Quality Commission’s latest summary of the state of health and social care points to an unfair and fragmented system
Echo co-founder Stephen Bourke tells Jack Carter how his app is simplifying the repeat prescription process
With the care village market still very much in its infancy in the UK, perhaps two of the biggest questions facing every care village developer, investor and operator are how much can we sell our care village apartments for, and will they hold their value? Carterwood director Ben Hartley provides some answers
Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners

Click here to search all feature articles



Deal in the spotlight

Elysium Healthcare's acquisition of LCP takes the group portfolio to more than 60 homes in just two years
Read more


Christie + Co

my images



Veterinary

Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners
Read more